Dr. Palmer / Ascletis : *Gannex, a wholly owned company

New Post Public Reply Private Reply Replies (1) Message Board
My69z
3,921
Dr. Palmer / Ascletis :

*Gannex, a wholly owned company of Ascletis Pharma Inc.

*I'm excited about joining Gannex which has three clinical stage assets in NASH, " said Dr. Palmer,

https://www.prnewswire.com/news-releases/gann...81353.html
___

** Gannex also has HIV programs
____

From Dec. 2020–to March 2022 Melissa Palmer, MD was the Chief Medical Officer of Gannex Pharma, a wholly owned company of Ascletis Pharma.

https://liverdisease.com/
___

Her employment history seems to go quiet after that, until

Cytodyn May 24, 2023:
"Mr. Migliarese will be supported by the Company’s recently appointed interim Chief Medical Officer, Dr. Melissa Palmer, ...."
___

Add Dr. Lataillade hiring:

*Dr. Lataillade will lead the Company’s global research and development strategy and oversee end-to-end R&D activities to advance the Company’s clinical development pipeline.

Days later Dr. Palmer hiring:

*In this role, Dr. Palmer will drive the Company’s strategy for research and development in Hepatology,
___

Back to Ascletis:

Ascletis Pharma Inc. is a drug development company in North Carolina that has connections to GlaxoSmithKline (GSK) through its founder and former GSK executive Dr. Jinzi Wu, and former GSK employee Allan Baxter:

Dr. Jinzi Wu
The founder of Ascletis, Dr. Wu was previously the Vice President of Global HIV Drug Discovery at GSK. He has over 20 years of experience in R&D, GMP manufacturing, and commercialization in the biotech and Big Pharma industries.

Allan Baxter
Baxter was the Global Head of Medicines Development at GSK before becoming the Chief Strategy Officer at Ascletis. He has been an advisor to Ascletis since the company's founding.
___

GSK influencing internal moves @ Cytodyn?

If you are in the yes camp, here's another twist/thought:

Late 2021 ViiV acquires the bNab used in our LL-PLS FcRn.

Jan. 25th, 2022 CEO fired.

May 2022 Dr. J outside Scientific Advisor.

Feb. 2023 our 2 key patents from Burger & Chen are granted.

GSK asked Cytodyn / Dr. J to take Interim & possibly into CEO with their backing?
___
Nov. 2023 Dr. J becomes Interim CEO.

Months later, CEO.

Dr. J later says it was a lot with Quest & Cytodyn & wasn't sure, but found he liked being CEO more than expected.

Dr. Lataillade left GSK controlled ViiV to oversee Cytodyn's pipeline & collaborations.

Has GSK been all around, in-directly involved with the Cytodyn turn-around, into 2024 & forward ?
___

Also, when the Pipeline was updated, Katango mentioned it would be nice if each indication had drop-down activity info.

Dr. Palmers words yesterday:

"....and explore new treatments that have the potential to truly transform patient outcomes.”

So far, we have HIV & MASH:
Could later be the start of those sub-attachments.

Ya just never know......

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 5

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading

Top 5 Most Recently Viewed Articles

RockFlow Secures Major Funding to Boost AI Capabilities and Expansion

Updated Category News Views 364

RockFlow's Significant Funding Boost for AI Development RockFlow, a pioneering fintech company based in Singapore, has recently announced the successful closure of a funding round, raising substantial capital to further its mission of revolutionizing financial services through artificial intelligence. Notably backed by Lanchi Ventures, RockFlow's fundraising efforts have...

Continue Reading
Upcoming £1 Billion Auction of Treasury Gilt 2054 in London

Updated Category News Views 228

Major Treasury Gilt Auction Scheduled for January The UK Debt Management Office has officially declared an important upcoming event for financial markets—a £1 billion auction of the 1¼% Index-linked Treasury Gilt set for January. This auction is significant as it represents a robust opportunity for investors interested in government bonds. Understanding the...

Continue Reading
Barclays Strengthens Canadian Investment Banking Team

Updated Category News Views 249

Barclays Expands Its Investment Banking Team in Canada Barclays has made significant leadership appointments in its Canadian Investment Banking division. Greg Petit steps in as the Head of Infrastructure, Power and Utilities for Canada, while Ken Davis takes on the role of Head of Western Canadian Coverage. Both leaders bring extensive experience that will enhance...

Continue Reading
Insights From the 2024 Elastic Global Threat Report

Updated Category News Views 84

Elastic (NYSE: ESTC) dropped the 2024 Elastic Global Threat Report, shining a harsh light on the shifting battlefield of cybersecurity. The numbers? Over one billion data points feeding insights that should make every trader sit up straight. It’s like the market's screaming at us—there’s a serious surge in adversarial activity thanks to easy-to-access offensive...

Continue Reading
GrantWatch Rolls Out Intelligence™ for Grant Seekers

Updated Category News Views 12

GrantWatch Reimagines Grant Research June 30, 2026, brought a new dawn in the world of grant research with the launch of GrantWatch Intelligence™. This isn’t just another tool—it’s a game-changer for nonprofits, businesses, schools, and a host of other organizations on the hunt for funding opportunities. We're talking about an innovative platform that combines...

Continue Reading